Granzyme A inhibition reduces inflammation and increases survival during abdominal sepsis

Archive ouverte

Garzón-Tituaña, Marcela | Sierra-Monzón, José | Comas, Laura | Santiago, Llipsy | Khaliulina-Ushakova, Tatiana | Uranga-Murillo, Iratxe | Ramirez-Labrada, Ariel | Tapia, Elena | Morte-Romea, Elena | Algarate, Sonia | Couty, Ludovic | Camerer, Eric | Bird, Phillip | Seral, Cristina | Luque, Pilar | Paño-Pardo, José | Galvez, Eva | Pardo, Julián | Arias, Maykel

Edité par CCSD ; Ivyspring International Publisher -

International audience. Aims: Peritonitis is one of the most common causes of sepsis, a serious syndrome characterized by a dysregulated systemic inflammatory response. Recent evidence suggests that Granzyme A (GzmA), a serine protease mainly expressed by NK and T cells, could act as a proinflammatory mediator and could play an important role in the pathogenesis of sepsis. This work aims to analyze the role and the therapeutic potential of GzmA in the pathogenesis of peritoneal sepsis. Methods: The level of extracellular GzmA as well as GzmA activity were analyzed in serum from healthy volunteers and patients with confirmed peritonitis and were correlated with the Sequential Organ Failure Assessment (SOFA) score. Peritonitis was induced in C57Bl/6 (WT) and GzmA-/- mice by cecal ligation and puncture (CLP). Mice were treated intraperitoneally with antibiotics alone or in combination serpinb6b, a specific GzmA inhibitor, for 5 days. Mouse survival was monitored during 14 days, levels of some proinflammatory cytokines were measured in serum and bacterial load and diversity was analyzed in blood and spleen at different times. Results: Clinically, elevated GzmA was observed in serum from patients with abdominal sepsis suggesting that GzmA plays an important role in this pathology. In the CLP model GzmA deficient mice, or WT mice treated with an extracellular GzmA inhibitor, showed increased survival, which correlated with a reduction in proinflammatory markers in both serum and peritoneal lavage fluid. GzmA deficiency did not influence bacterial load in blood and spleen and GzmA did not affect bacterial replication in macrophages in vitro, indicating that GzmA has no role in bacterial control. Analysis of GzmA in lymphoid cells following CLP showed that it was mainly expressed by NK cells. Mechanistically, we found that extracellular active GzmA acts as a proinflammatory mediator in macrophages by inducing the TLR4-dependent expression of IL-6 and TNFα. Conclusions: Our findings implicate GzmA as a key regulator of the inflammatory response during abdominal sepsis and provide solid evidences about its therapeutic potential for the treatment of this severe pathology.

Consulter en ligne

Suggestions

Du même auteur

Extracellular Granzyme A Promotes Colorectal Cancer Development by Enhancing Gut Inflammation

Archive ouverte | Santiago, Llipsy | CCSD

International audience. If not properly regulated, the inflammatory immune response can promote carcinogenesis, as evident in colorectal cancer (CRC). Aiming to gain mechanistic insight into the link between inflamm...

All-trans retinoic acid (ATRA) induces miR-23a expression, decreases CTSC expression and granzyme B activity leading to impaired NK cell cytotoxicity

Archive ouverte | Sánchez-Martínez, Diego | CCSD

International audience. NK cell is an innate immune system lymphocyte lineage with natural cytotoxicity. Its optimal use in the clinic requires in vitro expansion and activation. Cytokines and encounter with target ...

MicroRNAs: new candidates for the regulation of the human cumulus–oocyte complex

Archive ouverte | Sánchez-Martínez, Diego | CCSD

Chargement des enrichissements...